Prediction of cardiovascular risk in infants with bronchopulmonary dysplasia
- 作者: Tsareva Z.A.1, Tsarkova S.A.2, Belkina Y.L.2, Trunova Y.A.2
-
隶属关系:
- Children’s City Clinical Hospital No. 9
- Ural State Medical University
- 期: 卷 29, 编号 1 (2025)
- 页面: 27-34
- 栏目: Original study article
- URL: https://journal-vniispk.ru/RFD/article/view/292750
- DOI: https://doi.org/10.17816/RFD641961
- EDN: https://elibrary.ru/SLJZXA
- ID: 292750
如何引用文章
详细
BACKGROUND: Respiratory, neurological and other outcomes of bronchopulmonary dysplasia in infants are well documented. However, the incidence and severity of cardiovascular abnormalities require further research.
AIM: The aim of the study was to establish cardiovascular risk criteria in infants with bronchopulmonary dysplasia and develop a mathematical model to predict cardiovascular abnormalities.
METHODS: A total of 1931 perinatal discharge records were analyzed. The final analysis included 274 source records. The main group was divided into two subgroups: 91 infants with cardiovascular abnormalities and 46 infants without cardiovascular abnormalities. The analysis included 225 parameters of perinatal history, laboratory and functional diagnostic tests. Discriminant and correlation analyses were performed using SPSS for statistical data processing.
RESULTS: Cardiovascular abnormalities were found in 66.4% of infants with bronchopulmonary dysplasia at 3 months of age and were represented by morphological changes such as functional patent foramen ovale, patent ductus arteriosus, and prolonged exposure to these conditions. Circulatory failure, transient pulmonary hypertension and combinations of cardiovascular abnormalities were reported.
Nine significant cardiovascular risk factors were identified, such as patent ductus arteriosus, gestational age ≤ 32 weeks, use of two doses of surfactant, time of prenatal care enrollment, duration of mechanical ventilation and oxygen dependence > 28 days, grade III–IV cerebral ischemia, severe retinopathy, body weight < 1 kg.
A formula was developed to predict a low, moderate, or high cardiovascular risk (98%).
CONCLUSION: In infants with bronchopulmonary dysplasia at 3 months of age, estimated individual cardiovascular risk helps differentiate the approach to preventing heart and blood vessel damage.
作者简介
Zhanna Tsareva
Children’s City Clinical Hospital No. 9
编辑信件的主要联系方式.
Email: dmb9zhanna@yandex.ru
ORCID iD: 0009-0005-6459-763X
SPIN 代码: 6185-9920
俄罗斯联邦, Yekaterinburg
Sofya Tsarkova
Ural State Medical University
Email: tsarkova_ugma@bk.ru
ORCID iD: 0000-0003-4588-5909
SPIN 代码: 8649-9681
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, YekaterinburgYuliya Belkina
Ural State Medical University
Email: ybelkina287@gmail.com
ORCID iD: 0009-0000-3925-9122
SPIN 代码: 2492-6800
MD, Cand. Sci. (Medicine), Assistant Professor
俄罗斯联邦, YekaterinburgYuliya Trunova
Ural State Medical University
Email: trunovaj@bk.ru
ORCID iD: 0000-0001-9261-4111
SPIN 代码: 1938-9892
MD, Cand. Sci. (Medicine), Assistant Professor
俄罗斯联邦, Yekaterinburg参考
- Schmidt AR, Ramamoorthy C. Bronchopulmonary dysplasia. Paediatr Anaesth. 2022;32(2):174–180. doi: 10.1111/pan.14365
- Eriksson L, Haglund B, Odlind V, et al. Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2014;49(7):665–672. doi: 10.1002/ppul.22881
- Kusuda S, Fujimura M, Sakuma I, et al. Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics. 2006;118(4):e1130–1138. doi: 10.1542/peds.2005-2724
- Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–1051. doi: 10.1001/jama.2015.10244
- Sahni M, Mowes AK. Bronchopulmonary dysplasia. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539879/
- Poindexter BB, Feng R, Schmidt B, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the Prematurity and Respiratory Outcomes Program. Ann Am Thorac Soc. 2015;12(12):1822–1830. doi: 10.1513/AnnalsATS.201504-218OC
- Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006;117(3 Pt 2):S52–S56. doi: 10.1542/peds.2005-0620I
- Lagatta JM, Hysinger EB, Zaniletti I, et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. J Pediatr. 2018;203:218–224.e3. doi: 10.1016/j.jpeds.2018.07.035
- Valenzuela D, Moya F, Luco M, Tapia JL. The role of pulmonary hypertension on bronchopulmonary dysplasia. Rev Chil Pediatr. 2017;88(6):699–706. (In Spanish) doi: 10.4067/S0370-41062017000600699
- Mezu-Ndubuisi OJ, Agarwal G, Raghavan A, et al. Patent ductus arteriosus in premature neonates. Drugs. 2012;72(7):907–916. doi: 10.2165/11632870-000000000-00000
- Collaco JM, Romer LH, Stuart BD, et al. Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2012;47(11):1042–1053. doi: 10.1002/ppul.22609
- Bhandari A, McGrath-Morrow S. Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):132–137. doi: 10.1053/j.semperi.2013.01.010
- Starr MC, Wilson AC. Systemic hypertension in infants with bronchopulmonary dysplasia. Curr Hypertens Rep. 2022;24(6):193–203. doi: 10.1007/s11906-022-01179-4
- Bjorkman KR, Miles KG, Bellew LE, et al. Patent ductus arteriosus and lung magnetic resonance imaging phenotype in moderate and severe bronchopulmonary dysplasia-pulmonary hypertension. Am J Respir Crit Care Med. 2024;210(3):318–328. doi: 10.1164/rccm.202310-1733OC
- Barkhuizen M, Abella R, Vles JSH, et al. Antenatal and perioperative mechanisms of global neurological injury in congenital heart disease. Pediatr Cardiol. 2021;42(1):1–18. doi: 10.1007/s00246-020-02440-w
- Lanciotti L, Pasqualini M, Correani A, et al. Who needs a second dose of exogenous surfactant? J Pediatr. 2023;261:113535. doi: 10.1016/j.jpeds.2023.113535
- Arriola-Lopez AE, Martinez-Perez ME, Martinez-Castellanos MA. Retinal vascular changes in preterm infants: heart and lung diseases and plus disease. J AAPOS. 2017;21(6):488–491.e1. doi: 10.1016/j.jaapos.2017.08.004
- Sehgal A, Ruoss JL, Stanford AH, et al. Hemodynamic consequences of respiratory interventions in preterm infants. J Perinatol. 2022;42(9):1153–1160. doi: 10.1038/s41372-022-01422-5 Erratum in: J Perinatol. 2022;42(8):1147–1148. doi: 10.1038/s41372-022-01453-y
- Kayton A, Timoney P, Vargo L, Perez JA. A review of oxygen physiology and appropriate management of oxygen levels in premature neonates. Adv Neonatal Care. 2018;18(2):98–104. doi: 10.1097/ANC.0000000000000434
- Rolnik DL, Selvaratnam RJ, Wertaschnigg D, et al. Routine first trimester combined screening for preterm preeclampsia in Australia: A multicenter clinical implementation cohort study. Int J Gynaecol Obstet. 2022;158(3):634–642. doi: 10.1002/ijgo.14049
补充文件
